Penumbra Inc
General ticker "PEN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $9.5B
Penumbra Inc does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 1.6%: low 238.86$, high 246.58$
Factors to consider:
- US accounted for 71.5% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [197.22$, 319.04$]
- 2024-12-30 to 2025-12-30 estimated range: [194.48$, 318.57$]
Financial Metrics affecting the PEN estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 2.09
- Negative: Operating cash flow per share per price, % of 1.07 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.42
- Positive: 1.03 < Operating profit margin, % of 6.95
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 5.52
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
Short-term PEN quotes
Long-term PEN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $747.59MM | $847.13MM | $1,058.52MM |
| Operating Expenses | $755.09MM | $841.05MM | $984.97MM |
| Operating Income | $-7.50MM | $6.08MM | $73.55MM |
| Non-Operating Income | $-3.00MM | $-2.19MM | $6.10MM |
| Interest Expense | $1.93MM | $0.14MM | $1.74MM |
| R&D Expense | $104.55MM | $79.41MM | $84.42MM |
| Income(Loss) | $-10.50MM | $3.89MM | $79.65MM |
| Taxes | $-13.12MM | $5.89MM | $-11.30MM |
| Profit(Loss) | $2.62MM | $-2.00MM | $90.95MM |
| Stockholders Equity | $953.93MM | $998.86MM | $1,178.94MM |
| Inventory | $263.50MM | $334.01MM | $388.02MM |
| Assets | $1,244.25MM | $1,370.89MM | $1,556.31MM |
| Operating Cash Flow | $9.50MM | $-55.66MM | $97.33MM |
| Capital expenditure | $21.18MM | $19.30MM | $15.21MM |
| Investing Cash Flow | $-21.73MM | $54.79MM | $-16.08MM |
| Financing Cash Flow | $0.84MM | $11.62MM | $16.20MM |
| Earnings Per Share* | $0.07 | $-0.05 | $2.37 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.